Vaxil Provides Update on Preclinical Experiment
April 13, 2020 08:30 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States The Company is not making any express or implied claims that it has developed a vaccine to treat COVID-19 (or SARS-CoV-2) at this time ...
VAXIL COMMENCES PRECLINICAL COVID-19 VACCINE TRIAL AND FILES AN ADDITIONAL COVID-19 PATENT
March 27, 2020 09:10 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, March 27, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
VAXIL CHANGES WEBSITE DOMAIN NAME, PROVIDES UPDATE ON THE EXERCISE OF WARRANTS AND RECEIVES FINAL TSXV EXCHANGE APPROVAL ON THE DEBENTURE FINANCINGS
March 18, 2020 09:10 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, ISRAEL, March 18, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Provides Update Website, Lab Work and the Exercise of Warrants
March 16, 2020 09:10 ET
|
Vaxil Bio Ltd.
NOT FOR DISTRIBUTION BY US NEWSWIRE OR IN UNITED STATES NESS-ZIONA, Israel, March 16, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
VAXIL APPLIES FOR CORONAVIRUS VACCINE PATENT UNDER ITS ANTI-INFECTIVE VACCINES PLATFORM AND PROVIDES UPDATE ON THE EXERCISE OF WARRANTS
March 10, 2020 09:10 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, March 10, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Announces Closing of Bridge Financing and Provides Update on Corona Virus Vaccine Work
March 04, 2020 09:20 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, March 04, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Announces Financing Update
February 21, 2020 09:20 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Feb. 21, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Provides Clarification and Further Information on the Possible Identification of a Corona Virus Vaccine
February 18, 2020 12:28 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Feb. 18, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Announces the Identification of a Potential Corona Virus Vaccine and Provides an Update in the Previously Announced Debt Financing
February 13, 2020 16:05 ET
|
Vaxil Bio Ltd.
NESS-ZIONA, Israel, Feb. 13, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious...
Vaxil Announces Financing Update
January 28, 2020 10:14 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Jan. 28, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...